Impact of 68Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis

S Han, S Woo, YJ Kim, CH Suh - European urology, 2018 - Elsevier
Context 68 Gallium prostate-specific membrane antigen positron emission tomography (68
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …

Current evidence on the effect of dietary polyphenols intake on chronic diseases

C Costa, A Tsatsakis, C Mamoulakis, M Teodoro… - Food and Chemical …, 2017 - Elsevier
Polyphenols are secondary metabolites of plants. They comprise several antioxidant
compounds and they are generally considered to be involved in the defense against human …

[HTML][HTML] Improved outcomes with enzalutamide in biochemically recurrent prostate cancer

SJ Freedland, M de Almeida Luz… - … England Journal of …, 2023 - Mass Medical Soc
Background Patients with prostate cancer who have high-risk biochemical recurrence have
an increased risk of progression. The efficacy and safety of enzalutamide plus androgen …

Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease …

AC Westphalen, CE McCulloch, JM Anaokar, S Arora… - Radiology, 2020 - pubs.rsna.org
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active
surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) …

ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition …

M de Rooij, B Israël, M Tummers, HU Ahmed… - European …, 2020 - Springer
Objectives This study aims to define consensus-based criteria for acquiring and reporting
prostate MRI and establishing prerequisites for image quality. Methods A total of 44 leading …

EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from …

TBL Lam, S MacLennan, PPM Willemse, MD Mason… - European urology, 2019 - Elsevier
Background There is uncertainty in deferred active treatment (DAT) programmes, regarding
patient selection, follow-up and monitoring, reclassification, and which outcome measures …

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

HJ Boyle, S Alibhai, L Decoster, E Efstathiou… - European Journal of …, 2019 - Elsevier
Background The median age of prostate cancer diagnosis is 66 years, and the median age
of men who die of the disease is eighty years. The public health impact of prostate cancer is …

PI-RADS committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review

IG Schoots, JO Barentsz… - American Journal of …, 2021 - Am Roentgen Ray Soc
The steadily increasing demand for diagnostic prostate MRI has led to concerns regarding
the lack of access to and the availability of qualified MRI scanners and sufficiently …

Future platforms of robotic surgery

SL Alip, J Kim, KH Rha, WK Han - Urologic Clinics, 2022 - urologic.theclinics.com
The birth of robots in surgery and the idea of telepresence arose from necessity. One of the
factors that drove these innovations was the need to provide surgical services to soldiers in …

Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive …

GE Cacciamani, M Maas, N Nassiri, D Ortega… - European urology …, 2021 - Elsevier
Context Pelvic lymph node dissection (PLND) yields the most accurate staging in patients
undergoing radical prostatectomy (RP) for prostate cancer (PCa), although it can be …